Tenet Healthcare price target raised to $84 from $73 at RBC Capital

RBC Capital analyst Ben Hendrix raised the firm’s price target on Tenet Healthcare to $84 from $73 and keeps an Outperform rating on the shares. The company’s Q1 volume in both acute and ambulatory easily outpace assumptions included in management’s initial FY23 guidance, which together with impressive labor management drove an early-year guidance raise, the analyst tells investors in a research note.